Live Cell Imaging Market: Current Analysis and Forecast (2021-2027)

Live Cell Imaging Market: Current Analysis and Forecast (2021-2027)

The real-time study of cells using the images obtained from screening systems and microscopes is known as live-cell imaging. It plays a crucial role in understanding cell dynamics in various research fields including immunology, genetics, neurology, microbiology, etc. as it provides information with precision.

The live-cell imaging market is expected can be attributed to the rising prevalence of various chronic diseases coupled with a rapidly growing geriatric population. According to the United Nations, the 60+ aged population was 962 million in 2017 which is more than twice that it was in 1980 at 382 million. The number of elderly is expected to double again by 2050 and reach nearly 2.1 billion worldwide. Also, according to the Centers for Disease Control and Prevention, approximately 85% of older adults have at least one chronic health condition, and 60% have at least two chronic conditions. Owing to these facts, there is a growing demand for effective and quicker diagnostic facilities which can detect the disease at an early stage. Thereby, boosting the live cell imaging market.

Furthermore, with the growth in technological advancement and rising adoption of high content screening techniques, many industry players are focusing on launching new and advanced live cell imaging systems in the market globally. For example, in June 2021, CytoSMART Technologies launched two new fluorescence live-cell imaging systems, the Lux3 FL Duo Kit and the Multi Lux3 FL. The CytoSMART Lux3 FL Duo Kit is a compact and cost-effective imaging system consisting of two fluorescence microscopes and the CytoSMART Multi Lux3 FL fluorescence live-cell imaging system consists of four compact Lux3 FL devices, equipped with two fluorescent (green and red) and one brightfield channel.

Based on product, the live cell imaging market is segmented into equipment, consumables, and software. The consumables segment generated revenue of USD XX million in 2020 and it is estimated that it will exhibit a significant CAGR during the forecast period. Based on the technology, the live cell imaging market is segmented into time-lapse microscopy, fluorescence recovery after photobleaching, fluorescence resonance energy transfer, high content screening, and others. The fluorescence resonance energy transfer segment occupied the major market share in 2020 and it is expected to grow with a substantial CAGR in the forecast period.

Based on application, the market is fragmented into cell biology, developmental biology, stem cell & drug discovery, and others. The cell biology application segment grabbed XX% market share of the live cell imaging market and gathered revenue of USD XX million in 2020. The segment is expected to grow at a CAGR of XX% during the forecast period to reach a market valuation of USD XX million by 2027.

Based on the end-users, the market is fragmented into pharmaceutical & biotechnology companies, academic & research institutes, and contract research organizations(CROs). The pharmaceutical & biotechnology companies captured XX% market share in 2020. The market of this segment is expected to reach USD XX million by 2027.

For a better understanding of the market adoption of the Live Cell Imaging, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the live cell imaging industry and generated revenue of USD XX Million in 2020 owing to the growing adoption of technologically advanced techniques and an increase in the aging population in the region.

Some of the major players operating in the market are PerkinElmer, Inc., Becton, Dickinson and Company, Carl Zeiss AG, Danaher Corporation, Olympus Corporation, Sartorius AG, Thermo Fisher Scientific, Nikon Corporation, Biotek Instruments, Inc., CytoSMART Technologies, among others. Several M&A’s along with partnerships have been undertaken by these players to develop new and advanced live cell imaging systems.

The Global Live Cell Imaging Market was valued at USD XX million in 2020 and is projected to expand significantly with a CAGR of XX% from 2021 to 2027. The Live Cell Imaging Market is expected to witness a boost, owing to the rising prevalence of chronic diseases and the growing adoption of high-content screening techniques.